MRF-Logo2019-Horizontal-RGB
Merck-Rolling Submission-License Application for MK-3475
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Merck-Rolling Submission-License Application for MK-3475

› Forums › General Melanoma Community › Merck-Rolling Submission-License Application for MK-3475

  • Post
Viewing 5 reply threads
  • Replies
      • January 13, 2014 at 5:25 pm
      Mat
      Participant

        Jerry, thanks for posting.  The market certainly likes the news: "Shares of Merck & Co rose as much as 6 percent on Monday after the company filed the first part of an application to market its experimental drug, MK-3475, for advanced melanoma."

        Although not crystal clear, the wording of the article you posted suggests that the initial approval may be for those who have tried ipi first.

        To me, this also puts pressure on BMS to get nivo approved in 2014.

          • January 14, 2014 at 12:14 pm
          Tina D
          Participant

            Thank you for posting this article. Great article and great news!

            Tina

            • January 14, 2014 at 12:14 pm
            Tina D
            Participant

              Thank you for posting this article. Great article and great news!

              Tina

              • January 14, 2014 at 12:14 pm
              Tina D
              Participant

                Thank you for posting this article. Great article and great news!

                Tina

              • January 13, 2014 at 5:25 pm
              Mat
              Participant

                Jerry, thanks for posting.  The market certainly likes the news: "Shares of Merck & Co rose as much as 6 percent on Monday after the company filed the first part of an application to market its experimental drug, MK-3475, for advanced melanoma."

                Although not crystal clear, the wording of the article you posted suggests that the initial approval may be for those who have tried ipi first.

                To me, this also puts pressure on BMS to get nivo approved in 2014.

                • January 13, 2014 at 5:25 pm
                Mat
                Participant

                  Jerry, thanks for posting.  The market certainly likes the news: "Shares of Merck & Co rose as much as 6 percent on Monday after the company filed the first part of an application to market its experimental drug, MK-3475, for advanced melanoma."

                  Although not crystal clear, the wording of the article you posted suggests that the initial approval may be for those who have tried ipi first.

                  To me, this also puts pressure on BMS to get nivo approved in 2014.

                  • January 17, 2014 at 10:29 am
                  Golda_
                  Participant

                     I wish he would come sooner!

                     

                    • January 17, 2014 at 10:29 am
                    Golda_
                    Participant

                       I wish he would come sooner!

                       

                      • January 17, 2014 at 10:29 am
                      Golda_
                      Participant

                         I wish he would come sooner!

                         

                    Viewing 5 reply threads
                    • You must be logged in to reply to this topic.
                    About the MRF Patient Forum

                    The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

                    The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

                    Popular Topics